Live Breaking News & Updates on சிங்கப்பூர் கண் ஆராய்ச்சி நிறுவனம்

Stay updated with breaking news from சிங்கப்பூர் கண் ஆராய்ச்சி நிறுவனம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Scientists find gene mutation linked to exfoliation syndrome,most common cause of glaucoma


 E-Mail
IMAGE: Eye of a patient with exfoliation syndrome. The typical white exfoliation material deposits on the surface of the lens are visible (red arrows) with the aid of a slit lamp.
view more 
Credit: Agency for Science, Technology and Research (A STAR) s Genome Institute of Singapore,(GIS), Singapore Eye Research Institute (SERI)
SINGAPORE - A team of researchers from the Agency for Science, Technology and Research s (A STAR) Genome Institute of Singapore (GIS) and Bioprocessing Technology Institute (BTI), as well as Singapore Eye Research Institute (SERI), have identified a genetic mutation (functionally defective CYP39A1 gene) associated with exfoliation syndrome, the most common cause of glaucoma. The findings could pave the way for future research on the cause of exfoliation syndrome and potential cures. Their research was published in Journal of the American Medical Association (JAMA) on 24 February 2021. ....

United States , Harvard University , Diane Kaneb , David Friedman , Agency For Science , Ophthalmology At Harvard University , Technology Organisation , Journal Of The American Medical Association , Singapore Eye Research Institute , Genome Institute Of Singapore , Bioprocessing Technology Institute , Glaucoma Service , Genome Institute , American Medical Association , Patrick Tan , Executive Director , Maung Tin , Deputy Medical Director , Diane Kaneb Chair , Massachusetts Eye , Ear Infirmary , Precision Medicine , Population Genomics , Genome Informatics , Single Cell Systems , Epitranscriptomic Regulation ,

Johnson & Johnson Vision Announces Global Collaboration with Menicon to Bring Forward Contact Lenses to Help Manage the Progression of Myopia in Children


Johnson & Johnson Vision Announces Global Collaboration with Menicon to Bring Forward Contact Lenses to Help Manage the Progression of Myopia in Children
- This new collaboration combines expertise from Menicon Co., Ltd., a world-class manufacturer of innovative contact lenses with the science, scale and capabilities of Johnson & Johnson Vision
News provided by
Share this article
JACKSONVILLE, Fla., April 7, 2021 /PRNewswire/
 Johnson & Johnson Vision , a global leader in eye health and part of the Johnson & Johnson Medical Devices Companies , today announced a global strategic collaboration with Menicon, a leading manufacturer of innovative contact lenses. The collaboration is part of a broader commitment from Johnson & Johnson Vision to lead with science and help reshape the future of myopia – and bring forward a novel portfolio of products and services to manage the progression of myopia in children. ....

Ian Flitcroft , Peter Menziuso , Singapore Eye Research Institute , Singapore National Eye Centre , Johnson Medical Devices Companies , Johnson Medical Devices , Johnson Vision , Global President , Professor Ian Flitcroft , Private Securities Litigation Reform Act , சிங்கப்பூர் கண் ஆராய்ச்சி நிறுவனம் , சிங்கப்பூர் தேசிய கண் மையம் , ஜான்சன் மருத்துவ சாதனங்கள் நிறுவனங்கள் , ஜான்சன் மருத்துவ சாதனங்கள் , ஜான்சன் பார்வை , உலகளாவிய ப்ரெஸிடெஂட் , ப்ரைவேட் பத்திரங்கள் வழக்கு சீர்திருத்தம் நாடகம் ,

J&J Vision and Menicon Tackle Myopia with Contact Lens Collaboration


tashatuvango -stock.adobe.com
The collaboration comes on the heels of J&J winning approval from the Japanese Ministry of Health, Labour and Welfare for a contact lens that provides vision correction and an antihistamine drug to help relieve symptoms for people experiencing itchy allergy eyes.
Johnson & Johnson Vision is teaming up with Menicon, a developer of contact lenses to address myopia or near-sightedness in children.
The pact calls for Menicon to develop the contact lenses that would manage the progression of myopia. J&J Vision would focus on expanding the availability of the products across the world.
“For decades, Johnson & Johnson Vision has invested in research collaborations with academic centers, research institutes and leading global health organizations who share our vision of leading with science to reshape the future of myopia and eye health,” said Peter Menziuso, Global President, Johnson & Johnson Vision Care. “ ....

Peter Menziuso , Singapore Eye Research Institute , Singapore National Eye Centre , Japanese Ministry Of Health , Johnson Vision , Global President , Singapore Eye Research , Japanese Ministry , சிங்கப்பூர் கண் ஆராய்ச்சி நிறுவனம் , சிங்கப்பூர் தேசிய கண் மையம் , ஜப்பானிய அமைச்சகம் ஆஃப் ஆரோக்கியம் , ஜான்சன் பார்வை , உலகளாவிய ப்ரெஸிடெஂட் , சிங்கப்பூர் கண் ஆராய்ச்சி , ஜப்பானிய அமைச்சகம் ,